In-vitro transfer of nitazoxanide across the intestinal epithelial barrier

Journal of Pharmacy and Pharmacology

Volumn 54, Issue 10, 2002, Pages 1413-1417

  Matysiak Budnik, T ^a   Megraud F ^b   Heyman, M ^c  

^a INSERM   (France)

^b UNIVERSITÉ DE BORDEAUX   (France)

^c HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; NITAZOXANIDE; THIAZOLIDE; UNCLASSIFIED DRUG;

ANAEROBIC BACTERIUM; ANTIMICROBIAL ACTIVITY; ARTICLE; CANCER CELL CULTURE; CARCINOMA CELL; COLON CARCINOMA; CORRELATION FUNCTION; DRUG ACCUMULATION; DRUG DIFFUSION; DRUG EFFECT; DRUG TRANSPORT; HELICOBACTER PYLORI; HELMINTH; HUMAN; HUMAN CELL; IN VITRO STUDY; INTESTINE EPITHELIUM CELL; ISOTOPE LABELING; MICROPORE FILTER; MUCOSA; NONHUMAN; PROTOZOON; SEROSA; STEADY STATE;

ANTI-BACTERIAL AGENTS; CELL LINE; COLON; DIFFUSION CHAMBERS, CULTURE; ELECTROPHYSIOLOGY; HUMANS; INTESTINAL ABSORPTION; INTESTINAL MUCOSA; THIAZOLES; TIGHT JUNCTIONS; TUMOR CELLS, CULTURED;

EID: 0036796184     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/002235702760345518     Document Type: Article

References (17)

1. Broekhuysen, J., Stockis, A., Lins, R. L., De Graeve, J., Rossignol, J. F. (2000) Nitazoxanide: pharmacokinetics and metabolism in man. Int. J. Clin. Pharmacol. Ther. 38: 387-394
2. Dantzig, A. H., Bergin, L. (1988) Carrier-mediated uptake of cephalexin in human intestinal cells. Biochem. Biophys. Res. Commun. 155: 1082-1087
3. Dantzig, A. H., Bergin, L. (1990) Uptake of the cephalosporin, cephalexin, by a dipeptide transport carrier in the human intestinal cell line, Caco-2. Biochim. Biophys. Acta 1027: 211-217
4. Dubreuil, L., Houcke, I., Mouton, Y., Rossignol, J. F. (1996) In vitro evaluation of activities of nitazoxanide and tizoxanide against anaerobes and aerobic organisms. Antimicrob. Agents Chemother. 40: 2266-2270
5. Evans, D. G., Evans, D. J., Jr, Graham, D. Y. (1992) Adherence and internalization of Helicobacter pylori by HEp-2 cells. Gastroenterology 102: 1557-1567
6. Gargala, G., Delaunay, A., Li, X., Brasseur, P., Favennec, L., Ballet, J. J. (2000) Efficacy of nitazoxanide, tizoxanide and tizoxanide glucuronide against Cryptosporidium parvum development in sporozoite-infected HCT-8 enterocytic cells. J. Antimicrob. Chemother. 46: 57-60
7. Gilles, H. M., Hoffman, P. S. (2002) Treatment of intestinal parasitic infections: a review of nitazoxanide. Trends Parasitol. 18: 95-97
8. Heyman, M., Dumontier, A. M., Desjeux, J. F. (1980) Xylose transport pathways in rabbit ileum. Am. J. Physiol. 238: G326-G331
9. Heyman, M., Darmon, N., Dupont, C., Dugas, B., Hirribaren, A., Blaton, M. A., Desjeux, J. F. (1994) Mononuclear cells from infants allergic to cow's milk secrete tumor necrosis factor alpha, altering intestinal function. Gastroenterology 106: 1514-1523
10. Kok, J. W., Veldman, R. J., Klappe, K., Koning, H., Filipeanu, C. M., Muller, M. (2000) Differential expression of sphingolipids in MRP1 overexpressing HT29 cells. Int. J. Cancer 87: 172-178
11. Madara, J. L., Stafford, J. (1989) Interferon-gamma directly affects barrier function of cultured intestinal epithelial monolayers. J. Clin. Invest. 83: 724-727
12. Matysiak-Budnik, T., Terpend, K., Alain, S., Sanson le Pors, M. J., Desjeux, J. F., Mégraud, F., Heyman, M. (1998) Helicobacter pylori alters exogenous antigen absorption and processing across a digestive epithelial cell line. Infect. Immunol. 66: 5785-5791
13. Matysiak-Budnik, T., Thomas-Collignon, A., Megraud, F., Heyman, M. (2001) Alterations of epithelial permeability by Helicobacter and IL-1beta in vitro: protective effect of rebamipide. Dig. Dis. Sci. 46: 1558-1566
14. McVay, C. S., Rolfe, R. D. (2000) In vitro and in vivo activities of nitazoxanide against Clostridium difficile. Antimicrob. Agents Chemother. 44: 2254-2258
15. Megraud, F., Occhialini, A., Rossignol, J. F. (1998) Nitazoxanide, a potential drug for eradication of Helicobacter pylori with no cross-resistance to metronidazole. Antimicrob. Agents Chemother. 42: 2836-2840
16. Stockis, A., Deroubaix, X., Lins, R., Jeanbaptiste, B., Calderon, P., Rossignol, J. F. (1996) Pharmacokinetics of nitazoxanide after single oral dose administration in 6 healthy volunteers. Int. J. Clin. Pharmacol. Ther. 34: 349-351
17. Yamamoto, Y., Hakki, A., Friedman, H., Okubo, S., Shimamura, T., Hoffman, P. S., Rossignol, J. (1999) Nitazoxanide, a nitrothiazolide antiparasitic drug, is an anti-Helicobacter pylori agent with anti-vacuolating toxin activity. Chemotherapy 45: 303-312